Cardiac dysfunctions following spinal cord injury by Grigorean, VT et al.
Journal of Medicine and Life  Vol. 2, No.2, April-June 2009, pp.133-145  
  © 2009, Carol Davila University Foundation 
 
 
Cardiac dysfunctions following spinal cord injury 
 
Valentin Titus Grigorean* 
, ****, Aurelia Mihaela Sandu**, Mihai Popescu***,  
Mihai Aurelian Iacobini*, Rares Stoian* 
, ****,  Catalin Neascu*, Florian Popa****,
 
* “Bagdasar-Arseni” Clinical Emergency Hospital, Department of General Surgery, Bucharest, Romania  
** “Bagdasar-Arseni” Clinical Emergency Hospital, Department of Neurosurgery, Bucharest, Romania 
*** District Hospital Pitesti, Department of Neurosurgery, Pitesti, Romania 
**** “Carol Davila” University of Medicine and Pharmacy Bucharest, Romania 
 
Correspondence to:  Valentin Titus Grigorean, M.D. Ph.D 
Bagdasar-Arseni Clinical Emergency Hospital, Department of General Surgery 
10-12 Berceni Street, District 4, Bucharest, Romania 
 
 
Abstract 
The aim of this article is to analyze cardiac dysfunctions occurring after spinal cord injury (SCI). Cardiac 
dysfunctions  are  common  complications  following  SCI.  Cardiovascular  disturbances  are  the  leading  causes  of 
morbidity and mortality in both acute and chronic stages of SCI. 
We  reviewed  epidemiology  of  cardiac  disturbances  after  SCI,  and  neuroanatomy  and  pathophysiology  of 
autonomic nervous system, sympathetic and parasympathetic. 
SCI causes  disruption  of  descendent  pathways from central control centers to  spinal sympathetic  neurons, 
originating into intermediolateral nuclei of T1-L2 spinal cord segments.  Loss of supraspinal control over sympathetic 
nervous system results in reduced overall sympathetic activity below the level of injury and unopposed parasympathetic 
outflow through intact vagal nerve.  
SCI associates significant cardiac dysfunction. Impairment of autonomic nervous control system, mostly in 
patients with cervical or high thoracic SCI, causes cardiac dysrrhythmias, especially bradycardia and, rarely, cardiac 
arrest, or tachyarrhytmias and hypotension. Specific complication dependent on the period of time after trauma like 
spinal shock and autonomic dysreflexia are also reviewed. Spinal shock occurs during the acute phase following SCI 
and is a transitory suspension of function and reflexes below the level of the injury. Neurogenic shock, part of spinal 
shock, consists of severe bradycardia and hypotension. Autonomic dysreflexia appears during the chronic phase, after 
spinal  shock  resolution,  and  it  is  a  life-threatening  syndrome  of  massive  imbalanced  reflex  sympathetic  discharge 
occurring in patients with SCI above the splanchnic sympathetic outflow (T5-T6). Besides all this, additional cardiac 
complications, such as cardiac deconditioning and coronary heart disease may also occur.  
Proper  prophylaxis,  including  nonpharmacologic  and  pharmacological  strategies  and  cardiac  rehabilitation 
diminish  occurrence  of  the  cardiac  dysfunction  following  SCI.  Each  type  of  cardiac  disturbance  requires  specific 
treatment.  
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Spine  cord  injury  (SCI)  is  a  real  health 
problem, being one of the most devastating of all 
traumatic events.  
The  aim  of  this  article  is  evaluation  of 
cardiac  disturbances  following  SCI.  Cardiac 
dysfunctions  are  common  consequences  of  SCI 
and they represent an issue of interest worldwide. 
In  SCI  important  cardiovascular  dysfunctions 
occur  during  acute  and  chronic  stages.[1] 
Cardiovascular  disturbances  are  the  leading 
causes  of  morbidity  and mortality  in  both  acute 
and chronic stages of SCI.[2,4] Heart disease is 
the most common cause of death, accounting for 
approximately 30% of deaths.[3]  
Impairment of autonomic nervous control 
system, mostly in patients with cervical or high 
thoracic  SCI,  causes  cardiac  dysrrhythmias, 
especially bradycardia and rarely cardiac arrest or 
tachyarrhytmias,  and  hypotension.  Specific 
complication  dependents  on  the  period  of  time 
after trauma like spinal shock occurring during the 
acute  phase  and  autonomic  dysreflexia  found 
mostly  during  the  chronic  phase.  Besides, 
additional cardiac complications, such as cardiac 
deconditioning  and  coronary  heart  disease  may 
also occur.  
 
Epidemiology 
 
SCI has an annual incidence of 15 to 52.5 
cases per million population, and about 80% are 
young males, aged between 15 and 35 years, and 
5% are children.[1,5-9] Neurological disability is Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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frequently encountered, from all patients 53% are 
tetraplegic and 42% are paraplegic. 
Proper  treatment  of  cardiovascular 
dysfunctions  pays  an  important  role  in  the 
therapeutically  management  of  SCI.  By 
diminishing  the  cardiovascular  complications, 
morbidity  and  mortality  are  reduced  and  the 
quality  of  life  is  raised.  Cardiovascular 
dysfunctions  are  the  second  most  common 
underlying cause of death in chronic SCI, with a 
frequency  of  21.6%,  after  neoplasms.  They 
contribute  to  death  in  18.9%  of  cases.  Taking 
both,  underlying  and  contributing  causes, 
cardiovascular  dysfunctions  are  responsible  for 
40.5% of deaths, being the most common cause of 
mortality  in  patients  with  SCI.  [3]  The  most 
common  causes  of  death  are  cardiac  failure, 
ventricular  tachycardia,  atria  fibrillation,  cardiac 
arrest, atherosclerosis and coronary heart disease, 
cerebrovascular  disease,  rupture  of  abdominal 
aneurysm,  cardiomyopathy  and  ill-defined  heart 
disease. [3]  
100%  of  patients  sustaining  complete 
motor  cervical  SCI  (ASIA  A  and  B)  have 
bradycardia and 16% develop cardiac arrest. [1] In 
incomplete motor cervical SCI (ASIA C and D), 
35-71% develop bradycardia. [1] Extremely rare 
they have cardiac arrest. [1] In thoracolumbar SCI 
in only 13-35% of cases bradycardia occurs. [1]  
Besides,  in  this  particular  group  of 
patients,  lack  of  physical  activity,  obesity, 
hyperlipidemia,  insulin  resistance,  and  diabetes 
have a higher frequency in patients with SCI than 
in the general population. [1]  
 
Neuroanatomy  
 
Medial  prefrontal  cortex,  insula, 
hypothalamus, and cuneiform nucleus project into 
cardiovascular  nuclei  within  medulla  oblongata. 
[10-12] Parasympathetic impulses are carried out 
via  vagus  nerve.  Preganglionic  fibers  synapse 
with postganglionic parasympathetic neurons near 
myocardium.  Peripheral  vessels,  there  is  no 
parasympathetic outflow.  
Regarding  the  sympathetic  activity, 
preganglionic  neurons  are  situated  within  the 
lateral horn into intermediolateral nuclei of T1-L2 
cord segments. Heart sympathetic impulses arise 
from  T1-T4  spinal  cord  segments.  Sympathetic 
preganglionic  neurons  exit  the  spinal  cord  via 
ventral  root.  They  synapse  with  postganglionic 
neurons  situated  into  the  paravertebral 
sympathetic  chain.  Postganglionic  sympathetic 
fibers outflow through peripheral nerves to heart 
and vessels. 
 
Pathophysiology  
 
Besides  well-known  motor  and  sensitive 
deficits,  in  SCI,  autonomic  disturbances  are 
frequently  encountered.  Following  SCI  often 
occur  a  dysfunction  in  communication  between 
brainstem  and  autonomic  nervous  system. 
Autonomic  nervous  system  pays  a  highly 
important role in cardiovascular control. Impulses 
from autonomic nervous system, sympathetic and 
parasympathetic,  control  heart  rate,  and  blood 
pressure.  Sympathetic  and  parasympathetic 
nervous  systems  have  antagonistic  effects, 
adapted  to  various  needs.  Parasympathetic 
decreases heart rate. Sympathetic increases heart 
rate,  myocardic  contractibility,  raises  peripheral 
vascular  resistance  and  blood  pressure,  by 
inducing  vasoconstriction.  Heart  rate  and  blood 
pressure  control  depends  on  the  activity  of 
supraspinal  centers,  which  send  activator 
impulses,  through  descendent  pathways,  to 
sympathetic spinal preganglionar neurons.  
Secondary  to  SCI  descendent  pathways 
are interrupted and spinal circuits become unable 
to  generate  sympathetic  activity.  Disruption  of 
descendent  pathways  results  in  sympathetic 
hypoactivity  and  unopposed  parasympathetic 
outflow  through  intact  vagal  parasympathetic 
control.  Sympathetic  hypoactivity  results  in  low 
heart  rate,  reflex  bradycardia  and  rarely  cardiac 
arrest,  low  resting  blood  pressure,  orthostatic 
hypotension, loss of regular adaptability, loss of 
diurnal  fluctuation  of  blood  pressure  and 
disturbed reflex control.  
Because heart sympathetic impulses arise 
from  T1-T4  spinal  cord  segments,  complete 
cervical  and  high  thoracic  SCI  interferes  with 
superior  centers  control  over  spinal  sympathetic 
activity to the heart.  
Besides  autonomic  imbalance 
immediately after the trauma, a direct injury of the 
myocardium  occurs  due  to  massive  adrenergic 
mediators  releasing  from  the  suprarenal  glands 
and sympathetic nerves.  
As  subsequent  consequences  to  loss  of 
sympathetic activity, some morphological changes 
arise  into  preganglionic  sympathetic  neurons 
below the injury level and a hyperresponsiveness 
of  peripheral  alpha-adrenergic  receptors  are 
encountered.  It  is  not  established  yet  whether 
alpha-adrenergic  receptor  hyperresponsiveness  is 
a  consequence  of  receptor  hypersensitivity  or 
insufficient  presynaptic  uptake  of  the 
norepinephrine.[13] Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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During  the  acute  phase  of  SCI  patients 
develop  spinal  shock  with  neurogenic  shock.  
Autonomic dysreflexia and coronary heart disease 
are encountered during the chronic phase of SCI. 
Cardiac dysrrhythmias: bradyarrhythmias, such as 
bradycardia or asystola, or tachyarrhythmias, such 
as  paroxistic  supraventricular  tachycardia,  sinus 
tachycardia, atria flutter and atria fibrillation, and 
cardiac  deconditioning  occur  in  both  acute  and 
chronic stages.    
 
Cardiac dysfunctions occurring during the acute 
phase of SCI 
The  initial  response  to  SCI  is  a  short 
period  of  massive  sympathetic  stimulation  and 
reflex  parasympathetic  activity  that  usually  lasts 
for 3 to 4 minutes, mediated by alpha-adrenergic 
receptors. The patient develops reflex bradycardia 
or tachyarrhythmias and severe hypertension. The 
sympathetic  stimulation  is  due  to  massive 
norepinephrine  releasing  from  the  suprarenal 
glands  and  disruption  of  cervical  and  high 
thoracic vasoactive neurons.[14]  
After this immediate response to trauma, 
occurs  decrease  in  sympathetic  activity,  due  to 
interruption of descendent sympathetic pathways. 
Cardiac  output  and  total  peripheral  resistance 
decrease,  while  central  venous  pressure  remains 
unchanged.  The  patient  is  prone  to  bradycardia, 
hypotension,  and  hypothermia,  by  lack  of 
sympathetic activity and unopposed vagal tone.   
 
Spinal shock  
The  interruption  of  the  communication 
between  the  superior  centers  and  peripheral 
sympathetic intermediolateral thoracic and lumbar 
neurons leads to spinal shock.  
Spinal shock accompanies SCI during the 
acute phase and is a physiological disruption of all 
functions  of  the  spinal  cord.  It  is  a  transitory 
suspension  of  function  and  reflexes  below  the 
level of the injury. Activity of sympathetic spinal 
neurons is modulated by inputs from autonomic 
central  centers.  After  trauma  occurs  a  sudden 
disruption  of  communication  between  these 
centers  and  the  sympathetic  neurons  in  the 
intermediolateral thoracic and lumbar spinal cord 
leading to spinal shock. 
Spinal shock was first described by Whytt 
in 1750, and the term of “spinal shock” was later 
introduced into the literature by Hall in 1841.[15] 
The features of spinal shock are sensory deficits, 
flaccid paralysis, absence of deep tendon reflexes, 
abolishment  of  reflex  somatic  activity,  and 
thermoregulatory disturbances below the level of 
injury.  Etiology  and  pathogenesis  of  the  spinal 
shock  remain  controversial.  There  are  different 
theories  that  partially  explain  the 
phenomenon.[15,16]  Spinal  shock  involves 
different  aspects  according  to  the  level  of  cord 
injury.  In  high  cervical  SCI  occurs  acute 
respiratory failure, tetraplegia, anesthesia, lack of 
all reflexes below injury site, neurogenic shock, 
detrusor  and  rectum  areflexia,  ipsilateral  Horner 
syndrome  (ptosis,  enophthalmos,  miosis, 
anhidrosis).  In  low  cervical  SCI  there  is  no 
respiratory  failure,  because  respiratory  muscles 
are not affected. Patients with high thoracic SCI 
develop paraparesis. In low thoracic injuries there 
is  no  arterial  hypotension  and  no  neurogenic 
shock.[17]   
Neurogenic shock consists of bradycardia, 
severe  arterial  hypotension  and  hypotermia.[17-
20]    It  is  a  consequence  of  autonomic  nervous 
system malfunction, and it is caused by the lack of 
sympathetic activity, through loss of supraspinal 
control and unopposed parasympathetic tone via 
intact vagus nerve.[18-21] Systolic blood pressure 
below 90 mmHg in resting position, which is not 
a  result  to  low  intravascular  volume  due  to 
hemorrhage  or  dehydration,  is  characteristic  for 
neurogenic  shock.  Severe  arterial  hypotension 
usually requires vasopressors.[18,19,22] Severity 
of arterial hypotension and need for vasopressors 
are directly proportionate with the severity of the 
injury.[23] Cardiac output and peripheral vascular 
resistance deceases, while central venous pressure 
remains unchanged.[14]  
Spinal shock usually lasts days to weeks, 
with  an  average  of  4-12  weeks.[15,17-19,22,24-
27] There is no consensus regarding clinical signs 
that  defines  the  duration  of  spinal  shock. 
Appearance of bulbocavernous reflex, recovery of 
deep tendon reflexes or return of reflex detrusor 
functions are considered by different authors the 
endpoint  of  spinal  shock.  Ditunno  et  al.  believe 
that spinal shock consists of four phases: areflexia 
or hyporeflexia (0-24 hours), initial reflex return 
(1-3 days), early hyperreflexia (4  days-1 month) 
and spasticity (1-12 months).[28]  
Neurogenic shock should not be mistaken 
with  hypovolemic  shock.  In  neurogenic  shock, 
hypotension is associated with bradycardia, while 
in  hypovolemic  shock  tachycardia  occurs.  In 
neurogenic shock the skin is warm and dry, except 
for patients exposed to a cold environment. Care 
should  be  taken  because  neurogenic  and 
hypovolemic  shock  may  coexist,  and  when  this 
happens, neurogenic shock exacerbates the effects 
of  hypovolemic  shock  by  disabling  the 
vasoconstrictive  reflexes  that  ordinarily  preserve 
blood flow to vital organs.  Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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Cardiac dysfunctions occurring in both acute and 
chronic phase of SCI 
 
Cardiac dysrrhythmias  
The  risk  of  cardiac  dysrrhythmias  is 
higher during the acute phase and diminishes with 
time  passing.  Cardiac  dysfunctions  are  usually 
life-threatening  during  the  first  few  weeks  after 
the  injury.[18]  Even  though,  late  cardiac 
dysfunctions may occur during the chronic phase.  
Cardiac dysrrhythmias includes:  
A.  Bradyarrhythmias 
1.  Bradycardia  
2.  Asystola, cardiac arrest 
B.  Tachyarrhythmias 
1.  Paroxistic supraventricular tachycardia 
2.  Sinus tachycardia 
3.  Atria flutter 
4.  Atria fibrillation 
Ventricular bradyarrythmias are the most 
frequent  cardiac  dysfunctions  found  following 
SCI  in  both  acute  and  chronic  phase. 
Parasympathetic  outflow,  via  vagus  nerve, 
remains  intact,  inducing  reflex  bradycardia, 
especially in acute cervical SCI, and rarely cardiac 
arrest.[1,18]  
All  this,  plus  hypotension  lead  to 
hemodynamic  instability.[29-31]  Usually 
bradycardia  and  cardiac  arrest  occurring  during 
the  acute  phase  following  SCI  are 
temporary.[32,33]  The  frequency  of 
bradyarrhythmias peaked on day 4 after injury and 
gradually  declined  thereafter.  After  the  acute 
phase, the risk for arrhythmia diminishes.  
During the chronic phase of SCI,  
 
incidence  of  bradyarrhythmia  is  higher  in 
tetraplegics  and  is  rarely  found  in 
paraplegics.[18,32-35]  Late  asystole  requiring 
transvenous ventricular pacing was found during 
the chronic phase.[34]  
Dysrrhythmias,  particularly  atria  fibrilla-
tion, may also occur during episodes of autonomic 
dysreflexia  in  high  SCI.  It  require  immediate 
pharmacological  intervention  to  restore  the 
normal rhythm.[18,36,37]  
Bradycardia is found in 64-77% cases in 
cervical SCI. It is more frequently encountered in 
the acute phase, and is more severe in the first 2-6 
weeks after trauma.[1,18] Furlan et al. found that 
bradycardia  and  hypotension,  occurring 
immediately after trauma, persist in patients with 
severe  autonomic  cardiovascular  pathways 
impairment.  Patients  with  less  severe  pathways 
impairment  have  a  higher  ventricular  rate, 
although an abnormal heart rate is observed.[23]  
Bradycardia is any heart rate less than 60 
beats/minute.  
Grading of severity in bradycardia is the 
following: 
Mild  bradycardia:  the  patient  is 
asymptomatic,  systolic  arterial  blood  pressure  is 
maintained over 90 mmHg, without medication 
Moderate  bradycardia:  requires  medical 
intervention  for  increasing  heart  rate  or  for 
maintain adequate blood pressure 
Severe bradycardia: asystola 
On EKG bradycardia is most commonly 
found  (Fig.  1).  Tacharrymias  such  as  paroxistic 
supraventricular  tachycardia  (Fig.  2),  sinus 
tachycardia (Fig. 3), atria flutter (Fig. 4) and atria 
fibrillation (Fig. 5) may also be encountered. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Bradycardia due to an unopposed vagal activity in SCI above T1. 
 
Fig. 2. Paroxistic supraventricular tachycardia. 
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Patients  with  SCI  are  prone  for 
developing nonspecific changes on EKG, like ST 
segment  elevation.  Besides,  they  may  also 
develop  other  electric  abnormalities,  such  as 
premature  atria  contractions,  intraventricular 
conduction delay, bundle-branch block.[38]  
Tracheal suction, endotracheal intubation, 
laryngoscopy  and  other  tracheal  stimuli  may 
induce  cardiac  bradycardia  and  even  asystola, 
especially in the presence of hypoxia.[39]  Reflex 
bradycardia  and  cardiac  arrest  occur  due  to  a 
vago-vagal  reflex.  In  normal  conditions,  this 
reflex is opposed by sympathetic activity. During 
hypoxia  a  pulmonary-vagal  reflex  occurs.  It 
increases breathing rate and pulmonary inflation, 
as  a  response  to  hypoxia.  In  patients  with  SCI 
compensatory  sympathetic  activity  is  hindered. 
Pulmonary-vagal reflex activity is also hindered, 
because pulmonary inflation cannot increase with 
hypoxia during mechanical ventilation.[32,33,40] 
Bradycardia  or  cardiac  arrest  as  a  response  to 
tracheal  suction,  endotracheal  intubation, 
laryngoscopy or other tracheal stimuli are found 
mainly  during  the  acute  phase,  in  patients  with 
high  complete  cervical  SCI,  and  this  problem 
usually resolves within the first 2-6 weeks after 
SCI.  
Cardiac  arrhythmias  are  correlated  with 
the level and severity of SCI.[18,41-43]  
Autonomic cardiovascular control system 
influences heart rate through direct effects on the 
sinus  node  and  by  modulating  circulating  beta-
adrenergic  agonist  levels.  Heart  rate  variability 
establishes  in  a  quantitative  manner  different 
shifts in autonomic control. The use of heart rate 
variability  in  SCI  was  reported.[41,42-44]  The 
validity  of  this  noninvasive  technique  was  not 
investigated  in  patients  with  efferent  autonomic 
activity. Increasing in diminishing of both vagal 
and sympathetic activity is directly proportionate 
with the height and severity of the SCI.[41] Vagal 
activity  influences  both  low  frequency  and  high 
frequency  components  of  heart  rate  variability 
during supine and upright postures. Sympathetic 
activity  influences  only  the  low  frequency 
component of heart rate variability during upright 
position. 
Fig. 3. Sinus tachycardia. 
Fig. 4. Atria flutter. 
 
Fig. 5. Atria fibrilation. 
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In  high  and  complete  SCI  there  is  a  great 
reduction in both vagal and sympathetic activities, 
which  indicates  that  the  branches  of  the 
autonomic nervous system maintain a balance in 
the presence of SCI.[41]  
Spontaneous beat-to-beat variability in R-
R intervals in complete tetraplegic patients and in 
normal  individuals  was  accomplished  by 
autoregressive power spectral analysis. In healthy 
subjects  two  major  spectral  components  were 
found,  low  and  high  frequency,  while  in 
tetraplegic  patients  only  the  high  frequency 
component was noted. The authors conclude that 
the  disappearance  of  the  low  frequency 
component  in  tetraplegic  patients  is  due  to  the 
disruption  of  pathways  from  supraspinal 
cardiovascular  centers  to  the  peripheral 
sympathetic outflow, and that the cervical spinal 
sympathetic pathways may be instrumental in the 
genesis  of  the  low  frequency  component  in 
humans.[42]  
Variability  of  spontaneous  beat-to-beat 
systolic  blood  pressure  (Mayer  waves)  was 
investigated  by  means  of  autoregressive  power 
spectral  analysis.  In  tetraplegic  patients  the 
disappearance of the low frequency component in 
the  systolic  blood  pressure  variability  (Mayer 
waves) is presumably caused by the interruption 
of  the  spinal  pathways  linking  supraspinal 
cardiovascular  centers  with  the  peripheral 
sympathetic  outflow  and  the  cervical  spinal 
sympathetic pathways may be instrumental in the 
genesis of the Mayer waves in humans.[45]  
Spontaneous  beat-to-beat  heart  rate  was 
investigated  by  autoregressive  power  spectral 
analysis. The majority of the tetraplegic patients 
had  only  the  high  frequency  component  with 
center frequency respiratory frequency, marker of 
vagal  modulation  of  heart  rate.  In  tetraplegic 
patients presenting both high and low frequency 
component,  the  center  frequency  of  the  low 
frequency  component  was  lower  than  that  in 
normal  individuals,  and  the  power  of  the  high 
frequency  component  was  smaller  than  normal.  
The low frequency/high frequency power ratio, an 
index  of  sympatheticovagal  balance,  was  larger 
than  that  in  normal  individuals  The  center 
frequency of the low frequency component had a 
center  frequency  of  0.03-0.15  Hz,  and  it  is  a 
marker  of  sympathetic  and  vagal  modulation  of 
heart rate. In tetraplegic patients with intact spinal 
cord at T1-T4, the level from where the cardiac 
sympathetic nerves originate, the total power, low 
frequency  and  high  frequency  components  are 
smaller in normal subjects.[43]  
Vagal  and  sympathetic  activity  on  heart 
rate  variability  can  be  investigated  using 
pharmacological  blockade.  Atropine  reduces 
amplitudes of both low (0.04-0.15 Hz) and high 
frequency (0.15-0.40 Hz) power spectrums during 
supine  and  upright  postures.[18]  Propranolol 
reduces the low frequency amplitude with upright 
postures  and  has  little  effect  on  heart  rate  at 
rest.[18]  
Cardiovascular  control  studied  in 
complete cervical SCI, in patients with recent SCI 
and  previous  spinal  shock,  and  in  patients  with 
chronic SCI with reflex spinal cord  activity was 
investigated  by  measuring  blood  pressure,  heart 
rate,  plasmatic  levels  of  norepinephrine  and 
epinephrine  were  measured  at  rest,  during  and 
after  application  of  noxious  stimuli  below  the 
level of lesion.  
Average  resting  blood  pressure  in 
tetraplegic  patients  with  the  recent  SCI  was 
130/57mmHg  (mean  81  mmHg),  in  the  chronic 
SCI  107/55mmHg  (mean  73  mmHg),  compared 
with normal individuals   122/82 mmHg (mean 95 
mmHg).  
Average  heart  rate  at  rest  was  64 
beats/minute  in  acute  SCI,  73  beats/minute  in 
chronic  SCI  and  77  beats/minute  in  healthy 
individuals.  
In  the  acute  SCI  bladder  stimulation 
causes minimal changes in heart rate and plasma 
norepinephrine  and  epinephrine  levels.  In  the 
chronic  SCI  bladder  stimulation,  induce 
bradycardia  and  elevation  in  plasma 
norepinephrine but not in epinephrine levels. Cold 
stimuli in  recent  SCI  did  not  change  heart  rate. 
Resting  plasma  norepinephrine  and  epinephrine 
levels  in  both  the  recent  and  chronic  SCI  were 
lower than in normal subjects.[46]  
Clinicians commonly use the head-up tilt 
to  illuminate  alterations  in  sympathetic  cardiac 
modulation, which reflect the degree of autonomic 
dysfunction. Autonomic and cardiac responses to 
head-up  tilt  are  blunted  in  both  persons  with 
tetraplegia  and  paraplegia.[47]  In  fact,  persons 
with paraplegia had comparable increases in heart 
rate  during  head-up  tilt  as  nondisabled  persons, 
which were facilitated by the predominantly vagal 
withdrawal rather than the increased sympathetic 
activation  that  was  demonstrated  in  nondisabled 
subjects. Heart rate variability techniques could be 
used  to  noninvasively  assess  cardiac  autonomic 
control in persons with SCI, determine the degree 
of  sympathetic  disruption,  and  illuminate  the 
potential risk of developing cardiac dysrhythmias. 
During the acute rehabilitation period, heart rate 
variability  can  be  a  tool  for  monitoring 
improvements in autonomic outflow, and during 
the  chronic  phase  of  injury,  it  may  document 
gains  in  function  following  physical  and  phar-
macological interventions. Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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SCI  with  resultant  tetraplegia  or  high 
paraplegia  is  associated  with  significant 
dysfunction of the sympathetic nervous system. It 
occurs as a consequence of the loss of supraspinal 
control of the sympathetic nervous system. Below 
the  level  of  injury  occur  reduced  overall 
sympathetic  activities,  morphologic  changes  in 
sympathetic  preganglionic  neurons,  and  peripheral 
alpha-adrenoceptor  hyperresponsiveness.  Peripheral 
alpha-adrenoceptor hyperresponsiveness accounts for 
excessive pressor response in autonomic dysreflexia, 
decreased  blood  flow  in  the  peripheral 
microcirculation,  and  increased  susceptibility  to 
pressure sores.  
Alpha-adrenoceptor hyperresponsiveness may 
be  a  consequence  of  receptor  hypersensitivity  or  a 
failure of presynaptic reuptake of norepinephrine at the 
receptor level.[13]  
Cardiovascular  dysfunctions  improve  in 
time. The reasons are not totally understood, but 
synaptic reorganization or hyperresponsiveness of 
alpha receptors may play a role in it. So far there 
no  convincing  data  to  demonstrated  whether 
deafferented spinal cord can generate significant 
basal sympathetic activity.[14]  
 
Cardiovascular deconditioning 
Cardiovascular deconditioning occurs as a 
consequence of prolonged bed rest and it is a loss 
of orthostatic tolerance, characterized by postural 
tachycardia and postural hypotension, thought to 
be related to diminished blood volume, decreased 
muscle or tissue pressure in the extremities or to 
functional alterations in the sympathetic nervous 
system.[48]  Cardiovascular  deconditioning  is 
associated  with  altered  nitric  oxide 
metabolism.[2,49,50]  There  is  an  higher 
production level of nitric oxide in the heart, brain, 
kidney,  and  systemic  arteries,  and  a  decreased 
nitric  oxide  production  in  the  cerebral  arteries. 
Altered  nitric  oxide  metabolism  it  induces 
peripheral  vasodilatation,  with  hypotension,  and 
cerebral  vasoconstriction  with  cerebral 
hypoperfusion.  
Increased  release  of  nitric  oxide  and 
upregulation of nitric oxide synthase is associated 
with  orthostatic  intolerance  after  prolonged  bed 
rest.[50]  
Cardiovascular  deconditioning  is 
encountered in the acute phase, and its incidence 
is  diminished  with  progression  to  the  chronic 
phase, due to mobilization of the patient.  
 
Cardiac dysfunctions during the chronic phase of 
SCI 
Autonomic dysreflexia 
After  spinal  shock  resolution,  the 
deafferented  spinal  cord,  in  SCI  above  T6, 
generates  automonic  dysreflexia,  a  life-
threatening hypertensive bouts with compensatory 
bradycardia,  after  noxious  stimuli  or  bladder  or 
bowel  distension.  Autonomic  dysreflexia  is  the 
result  of  the  lack  of  supraspinal  control  of  the 
sympathetic  neurons  and  altered  glutamatergic 
neurotransmission within the spinal cord.[14]  
Autonomic  dysreflexia,  observed  for  the 
first  time  by  Anthony  Bowlby  in  1890,  and 
described  by  Guttmann  and  Whitteridge  in 
1947[51],  is  the  consequence  of  interruption  of 
control of the sympathetic spinal cord centers by 
central nervous centers, and it is a syndrome of 
massive imbalanced reflex sympathetic discharge 
to  stimuli  acting  below  the  level  of  injury. 
Noxious  stimuli  produce  disturbances  in  cardiac 
rhythm  and  profound  alterations  in  sympathetic 
vasomotor,  pilomotor  and  sudomotor  activity. 
Distension, stimulation or manipulation of bladder 
or  bowel  are  frequently  determinant 
factors.[24,27,51-54]  
Autonomic  dysreflexia  is  a  condition 
which may occur in individuals with SCI above 
the splanchnic sympathetic outflow, usually after 
cervical  SCI.  The  prevalence  varies  between  48 
and  90%  of  SCI  above  T6  [51,55,56],  but 
sometimes  autonomic  dysreflexia  was 
encountered in SCI as low as T10 [51]. Morbidity 
is  associated  with  the  hypertension,  which  can 
cause  retinal,  subarachnoid  or  intracerebral 
hemorrhage,  myocardial  infarction,  pulmonary 
edema  or  seizures.  Mortality  is  rare.  [51] 
Autonomic  dysreflexia  is  characteristic  for  the 
chronic  phase,  but  it  may  occur  any  time 
following  SCI.  It  is  rare  within  the  first  month 
following  SCI.  The  incidence  of  precocious 
autonomic dysreflexia, occurring within the first 
month after SCI is 5.2%. [2,57,58]  
After  spinal  shock  resolution,  the 
deafferented  spinal  cord,  in  injuries  above  T6, 
may  generate  aberrant  impulses  to  noxious 
stimuli, leading to autonomic dysreflexia, a life-
threatening  complication  of  SCI.  Autonomic 
dysreflexia  is  a  syndrome  of  reflex  sympathetic 
discharge from the preganglionic neurons in the 
thoracolumbar  spinal  cord  occurring  in  patients 
with  SCI  located  above  the  splanchnic 
sympathetic  outflow  T5-T6,  often  triggered  by 
distension  of  pelvic  viscera.  Autonomic 
dysreflexia  is  a  consequence  of  supraspinal 
control  loss  of  sympathetic  spinal  cord  neurons 
and  altered  glutamatergic  neurotransmission 
within  the  spinal  cord.[14]  Viscerosensitive 
impulses,  below  the  level  of  injury,  are Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
  140 
© 2009, Carol Davila University Foundation 
transmitted  through  intact  peripheral  sensory 
nerves,  through  ascendant  pathways  to  neurons 
located  within  the  intermediolateral 
thoracolumbar  nuclei,  releasing  a  sympathetic 
reflex.  Sympathetic  hyperstimulation  discharge 
high  quantities  of  norepinephrine,  dopamin-β-
hydroxilasis  and  dopamine,  which  leads  to 
massive  vasoconstriction  within  arterial  system, 
arterial hypertension, and cerebral vasodilatation. 
The  brain  perceives  the  hypertensive  crisis 
throughout cervical baroreceptors and IX and X 
nerves.  It  generates  inhibitory  impulses  that 
cannot be transmitted below the level of injury. 
Vasomotor  centers  from  the  medulla  oblongata 
tries  to  lower  arterial  blood  pressure,  by 
parasympathetic stimulation of the heart, through 
X nerve, generating severe bradycardia. 
The  development  of  autonomic 
dysreflexia  is  correlated  with  aberrant  sprouting 
of peptidergic afferent fibers into the spinal cord 
below  the  injury.  Sprouting  of  nerve  growth 
factor-responsive afferent fibers has been shown 
to have a major influence on dysreflexia, perhaps 
by  amplifying  the  activation  of  disinhibited 
sympathetic neurons.[59]  
Peripheral  alpha-adrenoreceptor 
hyperresponsiveness following SCI, and this may 
play  a  significant  role  in  the  development  of 
autonomic dysreflexia.[2]  
There  is  a  constellation  of  signs  and 
symptoms  in  SCI  above  T5-T6  in  response  to 
noxious or nonnoxious stimuli below injury level. 
Usually,  cardiac  response  encountered  during 
autonomic dysreflexia is reflex bradycardia. But 
autonomic  dysreflexia  may  present  also  with 
recurrent ventricular fibrillation and cardiac arrest, 
as  a  result  of  profound  effects  of  massive 
paroxysmal  sympathetic  activity  associated  with 
this condition.[52] Other clinical features includes 
severe arterial hypertension, headache and visual 
impairment  due  to  cerebral  vasodilatation, 
cutaneous  pallor  below  the  injury  site, 
piloerection,  secondary  to  sympathetic  activity, 
profuse  sweating  and  cutaneous  vasodilatation 
above  the  level  of  lesion,  secondary  to 
parasympathetic activity.  Arterial blood pressure 
can  reach  up  to  300  mmHg,  leading  to  retinal, 
intracerebral,  or  subarachnoid  hemorrhage, 
pulmonary  edema,  myocardial  infarction, 
seizures,  confusion  and  death.[27,60]  According 
to  increasing  blood  pressure,  there  are  three 
severity grades: mild/partial, when blood pressure 
increases  with  less  than  40  mmHg,  moderate, 
when blood pressure increases with more than 40 
mmHg, but systolic blood pressure is under 180 
mmHg, and severe, when systolic blood pressure 
increases over 180 mmHg. 
 
Coronary heart disease  
Coronary  heart  disease  accounts  for 
approximately 20% of deaths in SCI population. 
This  risk  of  coronary  heart  disease  may  be 
increasingly  important  as  the  life  expectancy  of 
people with SCI lengthens. 
Coronary heart disease increases after SCI 
due  to  physical  inactivity,  obesity, 
hyperlipidemia, insulin resistance, and diabetes.  
Abnormal lipid profile, with increasing in 
total  cholesterol  and  low-density  lipoprotein 
(LDL-cholesterol)  levels  and  diminishing  of  the 
high-density  lipoprotein  (HDL-cholesterol)  level 
occur in chronic SCI. The reason for diminishing 
of  the  HDL-cholesterol  is  still  on  debate.  It  is 
assumed  that  it  due  to  inappropriate  diet, 
adrenergic  dysfunction  and  lack  of  physical 
activity.[1]  The  ratio  of  total  cholesterol/HDL-
cholesterol  >  5  is  considered  high  risk  for 
coronary heart disease.[1]  
 
Treatment 
 
Treatment of neurogenic shock 
Treatment  of  neurogenic  shock  implies 
correction of bradycardia and hypotension. As a 
first step two venous lines should be established 
for  administration  of  resuscitation  fluids  and 
medications.  
The  treatment  of  neurogenic  shock  is 
individualized  for  each  patient,  and  depends  on 
the severity of heart rate dysfunctions and blood 
pressure.    
Hypotension,  associated  with  normal 
heart  rate  requires  volume  loading,  with 
crystalloids  and  colloids  within  the  first  24-48 
hours following SCI. If there is no concomitant 
hypovolemic  shock,  Hartmann’s  solution  is 
administrated  50-100  ml  per  hour,  in  order 
maintain a systolic blood pressure > 80 mmHg. If 
besides  neurogenic  shock  there  is  an  associated 
hypovolemic shock, normal saline or Hartmann’s 
solution is administrated with a rate big enough to 
increase intravascular volume and blood pressure.  
Patients  having  bradycardia  with  heart 
rate  <  60/minute  and  hypotension  with  systolic 
blood  pressure  <  90  mmHg,  require  0.5  mg 
atropine for low heart rate and sympathomimetics 
for hypotension, such as ephedrine, administrated 
intravenous  5  mg  or  subcutaneously  25-50  mg, 
every 4-6 hours.  
Heart  rate  <  50/minute,  nodal  or 
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higher doses of atropine administered as often as 
necessary up to 2 mg per hour.  
In severe neurogenic shock, monitoring of 
the central venous pressure is mandatory in order 
to  ensure  fluid  load  up  to  a  central  venous 
pressure  7-10  mmH2O.  If  hemodynamic 
instability  persists,  a  Swan  Ganz  catheter  is 
assembled.  It  provides  accurate  information  on 
cardiac  output,  heart  preload  and  systemic 
vascular  resistance.  In  cases  with  profound 
hemodynamic instability with low central venous 
pressure,  large  doses  of  vasopressors,  like 
norepinephrine,  dobutamine  and  dopamine  are 
required.  
Tisular  perfusion  must  be  maintained. 
Hypotension,  consequence  of  neurogenic  and/or 
hypovolemic shock causes spinal cord ischemia, 
cord  damage  and  extending  of  neurological 
deficit. In tetraplegic patients blood pressure must 
be  maintained  ranging  from  80/40  mmHg  to 
100/60 mmHg. Attention should be paid to fluid 
overload that can cause cord edema, which will 
further reduce tisular perfusion.  
 
Treatment of bradyarrhythmias 
Treatment of bradyarrhythmias consist of 
prophylactic  measures,  curative  treatment,  and 
cardiac rehabilitation.   
In  SCI  patients,  monitoring  heart  rate  is 
mandatory,  and,  if  indicated,  providing  support 
with medications to increase heart rate and blood 
pressure.  
The  first  line  therapy  for  bradycardia  is 
dopamine  administration.  Atropine  and 
transcutaneous pacer are used as the second line 
therapy in cases that do not respond to dopamine 
administration. Transvenous pacer is necessary in 
prolonged  or  excessive  bradycardia.  The  last 
treatment resource is permanent pacing, but it is 
rarely  necessary.  Aminophylline  and 
methylxanthines  given  in  patients  with  SCI  and 
low heart rate were associated with resolution of 
the  bradycardia.  They  were  used  to  prevent 
episodic bradyarrhythmias after SCI.[61]  
Prevention  of  bradycardia  and  cardiac 
arrest includes adequate oxygenation and atropine 
administration  before  tracheal  suction, 
laringoscopy or other maneuver that stimulate the 
trachea  in  all  artificially  ventilated  tetraplegic 
patients.[32,33,40]  Full  lung  expansion  before 
suctioning  may  decrease  vagal  tone,  therefore, 
provide  a  full  breath  with  a  ventilator  or  bag-
valve-mask resuscitator (Ambu-bag). 
Rehabilitation  program  includes  physical 
therapy.  Early  management  begins  with 
assessment  of  potential  exacerbating  factors, 
including  prolonged  recumbency,  rapid  changes 
in positioning, underlying infection, dehydration, 
and  drug  adverse  effects.  Before  moving  the 
patient out of supine position, abdominal binderm, 
thigh-high  antiembolism  stockings,  and  elastic 
bandages  to  the  lower  extremities  are  applied. 
These  measures  decrease  venous  pooling  in  the 
lower extremities and splanchnic vasculature. The 
patient is moved slowly, from a supine position to 
a  relatively  upright  position.  Using  a  tilt  table 
which slowly increases in degrees of tilt, can help 
the  patient  acclimate  to  an  upright  position. 
During the period of acclimatization, active arm 
exercises  are  useful  to  maintain  blood  pressure 
while the patient is on the tilt table.[1]  
Bilaterally  functional  electric  stimulation 
to  lower-limb  muscles,  quadriceps,  hamstrings, 
tibialis anterior and gastrocnemius, at an intensity 
that  provides  a  strong,  visible,  and  palpable 
contraction  during  postural  tilting  improves 
orthostatic  tolerance  in  patients  with  cervical 
complete  motor  SCI.  Functional  electric  muscle 
stimulation during tilting maneuver, significantly 
increase heart rate by 1.0+/-0.5 beats/minute, and 
attenuated the drop in systolic and diastolic blood 
pressure  for  every  15  degrees  increment  in  the 
angle of the tilt, and by this increasing the overall 
mean standing.[62]  
Other  exercises  that  increase  cardiac 
fitness  are  electrically  assisted  exercises  for  leg 
cycling, arm ergometry and ambulation.  
Cardiovascular  deconditioning  is 
reversible  by  training  by  increasing  vascular 
resistance in paralyzed legs.[63]  
Cardiac  rehabilitation  requires  special 
consideration  of  patient’s  inability  to  tolerate 
traditional  antianginal  medications,  because  of 
low blood pressures, and adaptations, progressive 
wheelchair propulsion, to address their limitations 
in mobility.  
 
Treatment  of  associated  orthostatic 
hypotension  
Treatment  of  associated  orthostatic 
hypotension  can  be  made  through 
nonpharmacological  and  pharmacological 
methods.  Mean  arterial  pressure  of  at  least  85 
mmHg  is  necessary  to  maintain  spinal-cord 
perfusion and help prevent secondary ischemia. 
Nonpharmacologic  measures  includes 
avoidance of precipitating factors of orthostathic 
hypotension,  such  as  diuretics,  alcohol,  caffeine 
and vasodilatory stresses [64-66], maintenance of 
plasma volume by increased salt and fluid intake 
[64,65], serving regular small meals that minimize 
postprandial  hypotension  [2,64,66],  wearing 
compression  bandages  and/or  support  stockings 
which  restrict  venous  pooling  in  the  splanchnic Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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region  and  limbs  [2,66]  and  maintenance  of 
elevated position of the head with 10-20°, during 
the night, this maneuver being known to increase 
plasma  volume  and  orthostatic  tolerance
67. 
Patients  should  be  advice  about  symptoms  of 
orthostatic  hypotension  and  they  should  be 
encouraged  to  assume  a  recumbent  or 
semirecumbent position if they occur. [64]  
Pharmacological therapy includes plasma 
volume  expansion  with  fludrocortisones  [68]  or 
increasing  peripheral  vasoconstriction  with  the 
alpha-adrenergic  agonist  midodrine.  [69,70]  In 
patients  with  more  refractory  symptoms, 
desmopressin  acetate  or  erythropoietin  can  be 
used.  [2]  Nitric  oxide  synthase  inhibitors  are 
currently  under  investigation,  and  results  seem 
promising. They normalize supine blood pressure 
in  SCI  with  tetraplegia.  [50]  Peripheral  alpha-
adrenoceptor  hyperresponsiveness  potentially 
increases susceptibility to pressure sores.  
 
Treatment of deep vein thrombosis 
Prophylaxis  of  deep  vein  thrombosis  is 
mandatory  through  nonpharmacologic 
prophylactic  strategies  including  early 
mobilization  of  the  patient,  thigh  high 
compression  stockings,  pneumatic  calf 
compression  boots  and  physical  therapy  and 
pharmacologic  prophylactic  treatment  consisting 
of  anticoagulant  therapy,  such  as  heparin,  low 
molecular weight heparin or oral anticoagulants.  
Heparin  administered  subcutaneously  is 
useful for reducing blood viscosity and improving 
flow.  Low  molecular  weight  heparin  has  been 
demonstrated  to  be  superior  to  standard  heparin 
preparations  and  the  former  also  significantly 
reduces the incidence of bleeding. Because of the 
high risk of developing deep vein thrombosis, in 
patients with SCI regular measurement of bilateral 
calf  and  thigh  circumferences  is  mandatory. 
Doppler  ultrasound  or  venograms  are  frequently 
performed to establish baselines. 
Curative  treatment  for  deep  vein 
thrombosis is represented by intravenous heparin 
for  7  to  10  days,  and  once  adequate 
anticoagulation  is  provided,  oral  anticoagulant 
therapy for 3 months. 
In  patients  in  whom  thromboembolism 
occurs  under  anticoagulation  therapy  or  for 
patients  with  high  risk  to  anticoagulant  therapy, 
an inferior vena cava filter can be placed. 
 
Treatment of autonomic dysreflexia 
Avoidance of trigger factors like noxious 
stimuli, bowel or bladder stimulation or distension 
prevents the occurrence of autonomic dysreflexia. 
Sympatholitic  drugs  administration  (alpha-
adrenergic  blocking  agents,  ganglionic  blockers, 
catecholamine  depleters),  vasodilators  drugs  and 
local  anesthetics  can  prevent  onset  of  this 
phenomenon.  [55,71,72]  Oral  terazosin  is 
administrated prophylactic. 
Treatment  of  autonomic  dysreflexia 
consists  of  elevated  position  of  head  and  trunk 
and  sublingual  administration  of  nifedipine  or 
nitroglycerine  for  immediate  effect.  Other  drugs 
used  are  mecamylamine,  diazoxide,  and 
phenoxybenzamine.  [51]  The  main  therapeutic 
issue is removal trigger factors, bladder and bowel 
decompression,  because  persistence  of  visceral 
stimuli  maintain  sympathetic  response.  [27] 
Analgesia  is  obtained  by  administration  of 
paracetamol  or  co-proxamol,  aspirin  or  non-
steroidal  anti-inflammatory  drugs  being 
contraindicated.  [24]  Unresponsive  patients  or 
with  poor  response  to  therapy  are  indicated  for 
regional  or  general  anesthesia,  that  successfully 
blocks sympathetic response. [56]   
 
Treatment of coronary heart disease and 
dyslipidemia  
Coronary  heart  disease  prevention  is 
based on avoidance of risk factors, including high 
blood  pressure,  smoking,  obesity,  physical 
inactivity, and cholesterol and/or lipid control.  
Lipid-lowering  drugs  are  used  used  for 
dyslipidemia.  Goals  for  optimal  cholesterol 
management  currently  include  an  LDL-
cholesterol  level  of  <  100  mg/dl,  and  total 
cholesterol of < 200 mg/dl.
1  
Resistive  exercise  therapy  can  improve 
arterial  health  after  chronic  SCI,  which  may 
reduce the risk of coronary heart disease.  
Aerobic  exercise  improves  lipid  profiles 
in patients with paraplegia but they less effect in 
patients with tetraplegia.  
 
Treatment of associated pathology 
Associated  pathology,  such  as  type  2 
diabetes  mellitus,  progressive  renal  and 
cardiovascular  disease  often  requires  additional 
treatment.  Angiotensin-converting  enzyme 
inhibitors  are  often  necessary  for  progressive 
renal  and  cardiovascular  disease.  Tetraplegic 
patients are tolerant of an acute bout of orthostatic 
stress after partial angiotensin-converting enzyme 
inhibitors administration. Although mean arterial 
blood  pressure,  is  reduced  immediately  after 
angiotensin-converting  enzyme  inhibitors 
administration,  it  is  after  that  maintained  with 
increasing  angles  of  tilt  and  no  symptoms 
occurred. [47]  
 
Pharmacological interactions 
Succinylcholine  must  be  avoided  in 
patients with SCI because it may induce cardiac 
arrest  and  hypokalemia  as  a  result  of 
hypersensitivity of muscle-cell membranes. Other 
medications  that  should  be  avoided  include Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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antihypertensives,  diuretics,  tricyclic 
antidepressants,  anticholinergics,  narcotic 
analgesics, and sildenafil. 
 
Conclusions 
 
Cardiac  dysfunctions  are  common 
consequences  following  SCI.  cardiovascular 
disturbances are the leading causes of morbidity 
and mortality in both acute and chronic phases of 
SCI.  Disruption  of  descendent  pathways  from 
superior  centers  to  spinal  sympathetic  neurons, 
originating into the intermediolateral nuclei of T1-
L2  spinal  cord  segments  results  in  an  reduced 
overall sympathetic activity and unopposed  
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